Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$20.23 - $23.33 $47.9 Million - $55.2 Million
-2,367,950 Reduced 21.02%
8,897,724 $188 Million
Q2 2023

Aug 11, 2023

BUY
$18.72 - $21.54 $115 Million - $132 Million
6,123,250 Added 119.07%
11,265,674 $231 Million
Q1 2023

May 12, 2023

BUY
$20.07 - $25.1 $103 Million - $129 Million
5,142,424 New
5,142,424 $109 Million

Others Institutions Holding AVTR

About Avantor, Inc.


  • Ticker AVTR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 674,035,008
  • Market Cap $15B
  • Description
  • Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...
More about AVTR
Track Nat Simons's Portfolio

Track Nat Simons Portfolio

Follow Nat Simons (Meritage Group LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Group LP and Nat Simons with notifications on news.